Cancer Research Institute (CRI)
CRI Lloyd J. Old STAR Program (Scientists TAking Risks)
January 15 annual deadline (Jan 15, 2026 deadline has passed; next cycle expected January 15, 2027). Interviews in Spring following deadline.
Last verified:
Details
| Funder | Cancer Research Institute (CRI) |
| Budget | $1.25M over 5 years |
| Duration | 5 years |
| Consortium | No |
| Application | 2-stage: application submission → invited virtual interview with CRI Scientific Advisory Council leadership |
| Frequency | Annual |
| Next round | 2027-01 |
Eligibility & scope
For mid-career cancer immunotherapy researchers: tenure-track assistant professors (≥3 years in role) or associate professors (≤3 years in role) with MD, PhD, or MD/PhD. Minimum 80% time commitment to research. Open internationally; research may be conducted at medical schools or research centers worldwide, but NOT at for-profit institutions. No citizenship restrictions. Unrestricted, flexible funding for high-risk, high-reward cancer immunotherapy research.
More from Cancer Research Institute (CRI)
CRI Irvington Postdoctoral Fellowship Program
Deadline: 1 Sept 2026$74k–$78k/year stipend + $5k/year institutional allowance (3 years)CRI Immuno-Informatics Postdoctoral Fellowship
Deadline: 1 Sept 2026$74k–$78k/year stipend + $5k/year institutional allowance (3-year award)Cri Ignite Award
$1.05MCRI Lloyd J. Old STAR Program
$1.25M
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free